Loading company…
Zurich-based company developing anaesthesia products, including an oral paediatric sedation solution approved in several EU markets.
Founded in 2010 in Zurich, Switzerland, Primex Pharmaceuticals Oy develops anaesthesia products for hospitals, surgical centres and other healthcare providers, including Recofol and OZASED. Its flagship is an oral solution for paediatric sedation that has regulatory approval in several EU markets. Founder Kari Sarvanto leads the company, and Innovestor invested in 2016, with financial terms undisclosed. It is listed at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in